|1.||O'Rahilly, Stephen: 2 articles (03/2015 - 10/2003)|
|2.||Agarwal, Anil K: 2 articles (02/2014 - 10/2003)|
|3.||Garg, Abhimanyu: 2 articles (02/2014 - 10/2003)|
|4.||Morselli, Eugenia: 1 article (11/2015)|
|5.||Tapia, Pablo: 1 article (11/2015)|
|6.||Cortés, Víctor A: 1 article (11/2015)|
|7.||Cautivo, Kelly: 1 article (11/2015)|
|8.||Fernández-Galilea, Marta: 1 article (11/2015)|
|9.||Rochford, Justin J: 1 article (03/2015)|
|10.||Talukder, Md Mesbah Uddin: 1 article (03/2015)|
11/06/2015 - "Mutations in 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) result in lipodystrophy, insulin resistance and diabetes. "
02/21/2014 - "In this study we examined the role of phosphatidic acid (PA) in hepatic glucose production (HGP) and development of hepatic insulin resistance in mice that lack 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2). "
|2.||Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)
03/01/2015 - "Disruption of the genes encoding either seipin or 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) causes severe congenital generalized lipodystrophy (CGL) in humans. "
12/01/2007 - "To analyze Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2) and 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) gene variation in a Chinese boy with CGL and his family. "
10/01/2003 - "Recently, mutations in 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) and Berardinelli-Seip congenital lipodystrophy 2 (BSCL2) genes were reported in pedigrees linked to chromosomes 9q34 and 11q13, respectively. "
|3.||Mood Disorders (Mood Disorder)
08/01/2010 - "Decreased expression or modification was observed for complexin 1 (CPLX1), alpha-synuclein, parvalbumin, ribosomal protein large P2, prohibitin, nerve growth factor, beta subunit (NGFB), peroxiredoxin 6 (PRDX6), 1-acylglycerol-3-phosphate O-acyltransferase 2_predicted, cystatin B (CYTB) and lysosomal membrane glycoprotein 1. CPLX1, the most strongly regulated protein observed, mediates the fusion of cellular transport vesicles with their target membranes and has been implicated in the pathophysiology of mood disorders, as well as antidepressant action. "
|1.||Phosphatidic Acids (Phosphatidic Acid)
|6.||Nerve Growth Factor (NGF)
|7.||Ribosomal Proteins (Ribosomal Protein)
|8.||Membrane Glycoproteins (Membrane Glycoprotein)